MedTrace Logo

Fentanyl Versus Midazolam as an Adjunct to Spinal Anesthesia

NCT06917898 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-04-09

No results posted yet for this study

Summary

It is well documented in the practice of anesthesia the effectiveness of bupivacaine when added with other adjuvants including midazolam, opioids, and ketamine during neuraxial spinal block for cesarean delivery, however comparison of the superiority of midazolam 2mg over fentanyl 25 micrograms or vice versa with bupivacaine during cesarean delivery has not been established and if performed diligently, could potentially change our understanding and current practice for better patient outcomes.

Conditions

  • Healthy Female Volunteer

Interventions

DRUG

Spinal Anesthesia with Bupivacaine and Fentanyl

25 mcg Fentanyl 12.5 mg Bupivacaine

DRUG

Spinal Anesthesia with Bupivacaine and Midazolam

2 Mg Midazolam 12.5 mg Bupivacaine

Sponsors & Collaborators

  • Makassed General Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-01
Primary Completion
2026-04-30
Completion
2026-04-30

Countries

  • Lebanon

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06917898 on ClinicalTrials.gov